Purdue Loses Bid To Fuse Jumble Of OxyContin Patent Suits
Law360, Boston (December 13, 2017, 6:00 PM EST) -- Purdue Pharma LP lost an attempt on Wednesday to squeeze several oxycodone-related patent lawsuits into one trial in Massachusetts federal court, a minor setback in the manufacturer’s claims seeking to guard the legal underpinnings of painkiller OxyContin.
U.S. District Judge F. Dennis Saylor indicated he could be swayed to reconsider combining Purdue’s three cases against Collegium Pharmaceutical Inc. if they reach the trial phase, and allowed the parties to immediately consolidate court filings to “ease an administrative burden.”
“From my standpoint, it’s better to have one trial than two, but I am not prepared to make that decision now,” Judge Saylor...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.